XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense and Resulting Deferred Tax Benefits
Stock-based compensation expense and the resulting deferred tax benefits were as follows (in thousands):
Year Ended June 30,
202220212020
Pre-tax stock-based compensation expense$46,229 $35,425 $20,706 
Deferred tax benefit (a)
8,787 6,167 3,014 
Total stock-based compensation expense, net of tax$37,442 $29,258 $17,692 
_________________________________
(a)For the years ended June 30, 2022 and 2021, the deferred tax benefit was reduced by $3.0 million attributable to stock-based compensation expense that is nondeductible for tax purposes pursuant to Section 162(m) as amended by the Tax Cuts and Jobs Act of 2017.
Schedule of Restricted Stock Units
The following table includes information related to restricted stock, performance share awards and stock options for the year ended June 30, 2022:
Restricted StockPerformance Share AwardsStock Options
Number of AwardsWeighted Average Fair Value at Grant DateNumber of AwardsWeighted Average Fair Value at Grant DateNumber of OptionsWeighted Average Exercise Price
Outstanding at June 30, 2021990,301 $35.27 1,731,002 $35.56 2,163,006 $30.32 
Granted658,389 37.74 651,392 37.22 — — 
Vested/exercised(295,854)40.16 (588,142)43.74 (1,252,486)30.21 
Forfeited(151,706)33.96 (215,457)32.18 (14,166)36.77 
Outstanding at June 30, 20221,201,130 $35.59 1,578,795 $33.66 896,354 $30.38 
Stock options outstanding and exercisable at June 30, 2022896,354 $30.38 
Schedule of Performance Share Awards
The following table includes information related to restricted stock, performance share awards and stock options for the year ended June 30, 2022:
Restricted StockPerformance Share AwardsStock Options
Number of AwardsWeighted Average Fair Value at Grant DateNumber of AwardsWeighted Average Fair Value at Grant DateNumber of OptionsWeighted Average Exercise Price
Outstanding at June 30, 2021990,301 $35.27 1,731,002 $35.56 2,163,006 $30.32 
Granted658,389 37.74 651,392 37.22 — — 
Vested/exercised(295,854)40.16 (588,142)43.74 (1,252,486)30.21 
Forfeited(151,706)33.96 (215,457)32.18 (14,166)36.77 
Outstanding at June 30, 20221,201,130 $35.59 1,578,795 $33.66 896,354 $30.38 
Stock options outstanding and exercisable at June 30, 2022896,354 $30.38 
Schedule of Stock Options Awards
The following table includes information related to restricted stock, performance share awards and stock options for the year ended June 30, 2022:
Restricted StockPerformance Share AwardsStock Options
Number of AwardsWeighted Average Fair Value at Grant DateNumber of AwardsWeighted Average Fair Value at Grant DateNumber of OptionsWeighted Average Exercise Price
Outstanding at June 30, 2021990,301 $35.27 1,731,002 $35.56 2,163,006 $30.32 
Granted658,389 37.74 651,392 37.22 — — 
Vested/exercised(295,854)40.16 (588,142)43.74 (1,252,486)30.21 
Forfeited(151,706)33.96 (215,457)32.18 (14,166)36.77 
Outstanding at June 30, 20221,201,130 $35.59 1,578,795 $33.66 896,354 $30.38 
Stock options outstanding and exercisable at June 30, 2022896,354 $30.38 
Schedule of Unrecognized Compensation
Unrecognized stock-based compensation expense at June 30, 2022 was as follows (in thousands). At June 30, 2022, there was no unrecognized stock-based compensation expense for outstanding stock options.
Unrecognized Stock-Based Compensation ExpenseWeighted Average Amortization Period
Restricted stock$22,082 1.9 years
Performance share awards20,553 1.6 years
Total unrecognized stock-based compensation expense$42,635 1.8 years
Summary of the Aggregate Intrinsic Value of Stock Options
The aggregate intrinsic value of stock options at June 30, 2022 was as follows (in thousands):
Intrinsic Value of Stock Options
Outstanding and exercisable$4,768 
Exercised during the year ended June 30, 20229,765